Wells Fargo & Company Issues Positive Forecast for Mettler-Toledo International (NYSE:MTD) Stock Price

Mettler-Toledo International (NYSE:MTD) had its price target lifted by Wells Fargo & Company from $1,225.00 to $1,450.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an “equal weight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s target price would suggest a potential upside of 0.39% from the stock’s previous close.

Several other equities analysts have also recently issued reports on MTD. Barclays lifted their price objective on Mettler-Toledo International from $1,300.00 to $1,575.00 and gave the company an “overweight” rating in a research note on Monday. Robert W. Baird dropped their price objective on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a research report on Monday, May 11th. Wall Street Zen cut shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Citigroup dropped their target price on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a report on Friday, May 8th. Finally, Stifel Nicolaus lifted their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a report on Monday. Six research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $1,445.36.

Mettler-Toledo International Price Performance

NYSE:MTD traded up $28.00 during trading hours on Monday, reaching $1,444.30. 19,882 shares of the company were exchanged, compared to its average volume of 177,269. The firm has a market cap of $29.19 billion, a PE ratio of 32.44, a price-to-earnings-growth ratio of 2.92 and a beta of 1.23. The stock’s 50-day moving average is $1,237.30 and its 200-day moving average is $1,274.51. The company has a current ratio of 1.12, a quick ratio of 0.78 and a debt-to-equity ratio of 159.45. Mettler-Toledo International has a twelve month low of $1,023.05 and a twelve month high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $11.46 EPS for the quarter, topping the consensus estimate of $10.80 by $0.66. The business had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.03 billion. Mettler-Toledo International had a negative return on equity of 1,212.14% and a net margin of 21.91%.The company’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $10.09 EPS. Mettler-Toledo International has set its FY 2026 guidance at 47.150-47.500 EPS and its Q3 2026 guidance at 12.000-12.150 EPS. On average, sell-side analysts anticipate that Mettler-Toledo International will post 47.25 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Mettler-Toledo International

Several hedge funds have recently modified their holdings of MTD. Capital International Investors grew its position in Mettler-Toledo International by 12.7% during the 4th quarter. Capital International Investors now owns 969,067 shares of the medical instruments supplier’s stock worth $1,351,064,000 after purchasing an additional 109,508 shares during the last quarter. T. Rowe Price Investment Management Inc. increased its position in shares of Mettler-Toledo International by 0.5% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 691,565 shares of the medical instruments supplier’s stock valued at $964,174,000 after acquiring an additional 3,157 shares during the period. Geode Capital Management LLC raised its stake in Mettler-Toledo International by 2.4% in the 4th quarter. Geode Capital Management LLC now owns 597,448 shares of the medical instruments supplier’s stock worth $830,879,000 after acquiring an additional 14,106 shares during the last quarter. Norges Bank acquired a new stake in Mettler-Toledo International during the 4th quarter worth about $520,989,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Mettler-Toledo International by 0.4% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 272,829 shares of the medical instruments supplier’s stock valued at $380,375,000 after purchasing an additional 1,052 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.